)
Edge20 Mar 2026
Tetra Pak: The Shape of Innovation
The story of Tetra Pak, the Rausing family, and how a paper tetrahedron gave rise to a company that now delivers almost 180 billion packages a year.
FibroBiologics
FibroBiologics (FBLG) investor relations material
FibroBiologics Registration filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Registration filing summary27 Mar, 2026
Company overview and business model
Clinical-stage biotechnology company developing fibroblast-based therapies for chronic diseases, including wound healing, multiple sclerosis, degenerative disc disease, psoriasis, certain cancers, and human longevity applications.
Most advanced product candidates are CYWC628, CYPS317, CYMS101, and CybroCell.
Formed in April 2021, converted to a Delaware corporation in December 2021, with principal offices in Houston, Texas.
Financial performance and metrics
Historical net tangible book value as of December 31, 2025, was $6.2 million or $1.8509 per share.
Pro forma as adjusted net tangible book value after the offering would be $11.2 million, or $1.4189 per share.
Immediate dilution to new investors is $2.9811 per share based on the assumed offering price.
Use of proceeds and capital allocation
Estimated net proceeds of $4.3 million, assuming no sale of Pre-Funded Warrants and no exercise of Warrants.
Proceeds intended for working capital and general corporate purposes.
Management retains broad discretion over the use of proceeds.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from FibroBiologics
- Net loss rose to $18.6M as R&D spending increased, with clinical trials set for 2026.FBLG
Q4 202525 Feb 2026 - All proposals passed, advancing a regenerative medicine pipeline and key share issuances.FBLGEGM 202620 Feb 2026
- Fibroblast-based therapies show strong preclinical and early clinical promise across multiple indications.FBLGJones Healthcare Seaside Summit 20243 Feb 2026
- Fibroblast therapy advances toward clinical trials, targeting chronic wounds and immune disorders.FBLGMaxim Group’s 2024 Healthcare Virtual Summit19 Jan 2026
- Key votes include a reverse stock split and approval of major new share issuances.FBLGProxy Filing29 Dec 2025
- Board seeks approval for reverse split and stock issuances to maintain Nasdaq listing.FBLGProxy Filing29 Dec 2025
- Registering 22.5M shares for resale, with up to $7.5M in potential proceeds, amid high risk.FBLGRegistration Filing23 Dec 2025
- Proxy seeks approval for reverse split, major stock issuances, and Board-backed governance changes.FBLGProxy Filing18 Dec 2025
- Vote on reverse stock split and warrant share issuances to maintain Nasdaq listing.FBLGProxy Filing18 Dec 2025
Next FibroBiologics earnings date
Q1 20261 May, 2026
FibroBiologics
Next FibroBiologics earnings date
Q1 20261 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage